甲福明通过调节MAPK通路来抑制AtT20细胞中的细胞增殖和ACTH分泌
Yingxuan Sun1, Jianhua Cheng1, Ding Nie1
1Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Molecular and cellular endocrinology
|December 26, 2023
概括
甲胺通过抑制MAPK通路,有效地抑制垂体瘤生长和上腺皮质激素 (ACTH) 分泌. 这表明甲福明是对库辛病的潜在治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 垂体皮质瘤会导致过多的ACTH分泌,导致库辛病.
- 目前对库辛病的治疗有局限性,需要新的治疗策略.
研究的目的:
- 为了研究甲胺对ACTH分泌和垂体瘤进展的影响.
- 阐明甲福林作用背后的分子机制,重点关注MAPK通路.
主要方法:
- 在体外研究中,使用与甲福明治疗的AtT20细胞,评估细胞活力,ACTH分泌,细胞循环和蛋白质表达.
- RNA测序以识别差异表达的基因和途径.
- 在裸体小鼠体内异种移植模型,以评估甲胺对瘤生长和ACTH水平的影响.
主要成果:
- 甲胺抑制了AtT20细胞增殖,降低了ACTH分泌,并诱导了G1/S阶段停止.
- RNA测序确定了MAPK通路的参与,并观察到ERK1/2和JNK的酸化降低.
- 与甲福明和ERK1/2抑制剂的联合治疗显示出增强抑制增殖和POMC表达.
- 在体内研究证实了甲福明抑制瘤生长和ACTH分泌.
结论:
- 梅特福明显示出作为治疗性瘤和库辛病的治疗剂的潜力.
- 药物的疗效可能通过抑制MAPK信号通路来调节.
- 对库辛病进行进一步的临床研究是有必要的.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


